0 items USD 0.00Search
Your search for "mrrpb5 global united states european union china 3d fabrics market research report 2019 2025" gave back 961 results.
Indian government has banned the use of Colistin, the last-resort antibiotic in livestock. Its use is widespread in Indian poultry. Such move would...
Rockville Research
February 2019
Price: USD 1,100.00
Nestle India Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
May 2022
Price: USD 175.00
General Insurance Corporation of India - Strategy, SWOT and Corporate Finance Report Summary General Insurance Corporation of India - Strategy, SWOT...
Catalog:
MarketLine
March 2022
Price: USD 175.00
Arvind Ltd - Strategy, SWOT and Corporate Finance Report Summary Arvind Ltd - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
Union Bank of India - Strategy, SWOT and Corporate Finance Report Summary Union Bank of India - Strategy, SWOT and Corporate Finance Report, is a...
Catalog:
MarketLine
September 2022
Price: USD 175.00
Textile Mills in India Summary Textile Mills in India industry profile provides top-line qualitative and quantitative summary information including:...
Catalog:
MarketLine
August 2020
Price: USD 350.00
Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
January 2023
Price: USD 175.00
Textile Mills in India - Market Summary, Competitive Analysis and Forecast to 2025 Summary Textile Mills in India industry profile provides top-line...
Catalog:
MarketLine
October 2021
Price: USD 350.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
